img

Global Prostate Cancer Treatment Drugs Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Prostate Cancer Treatment Drugs Market Research Report 2024

Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players are investing in research for the development of therapeutic products for the treatment of such tumors. For instance, there is a strong pipeline of products such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), ODM-201 (Orion and Bayer), which are in their phase 3 studies and are projected to enter the market in the near future. In addition, many generic products are likely to enter the market owing to the expiry of patents of the major existing products during the forecast period. Thus, these factors are expected to drive growth.
According to MRAResearch’s new survey, global Prostate Cancer Treatment Drugs market is projected to reach US$ 18760 million in 2033, increasing from US$ 14310 million in 2022, with the CAGR of 4.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prostate Cancer Treatment Drugs market research.
Asia Pacific is anticipated to be the fastest growing market over the forecast period. Rising awareness of such tumors would primarily drive growth. Governments of various countries in this region are playing a vital role in creating awareness through programs and online portals that provide detailed information regarding screening & diagnosis through PSA blood tests and DRE for male patients over 50 years of age.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Prostate Cancer Treatment Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Johnson & Johnson
Astella
Sanofi
Ipsen
Bayer
AstraZeneca
Dendreon
Segment by Type
Zytiga
Gonax
Lupron
Zoladex
Decapeptyl
Eligard
Vantas
Casodex
Others

Segment by Application


Hospitals
Ambulatory Surgical Centers
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Prostate Cancer Treatment Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Zytiga
1.2.3 Gonax
1.2.4 Lupron
1.2.5 Zoladex
1.2.6 Decapeptyl
1.2.7 Eligard
1.2.8 Vantas
1.2.9 Casodex
1.2.10 Others
1.3 Market by Application
1.3.1 Global Prostate Cancer Treatment Drugs Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Treatment Drugs Market Perspective (2018-2033)
2.2 Prostate Cancer Treatment Drugs Growth Trends by Region
2.2.1 Global Prostate Cancer Treatment Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Prostate Cancer Treatment Drugs Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Treatment Drugs Forecasted Market Size by Region (2024-2033)
2.3 Prostate Cancer Treatment Drugs Market Dynamics
2.3.1 Prostate Cancer Treatment Drugs Industry Trends
2.3.2 Prostate Cancer Treatment Drugs Market Drivers
2.3.3 Prostate Cancer Treatment Drugs Market Challenges
2.3.4 Prostate Cancer Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Treatment Drugs Players by Revenue
3.1.1 Global Top Prostate Cancer Treatment Drugs Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Treatment Drugs Revenue
3.4 Global Prostate Cancer Treatment Drugs Market Concentration Ratio
3.4.1 Global Prostate Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Treatment Drugs Revenue in 2022
3.5 Prostate Cancer Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Treatment Drugs Product Solution and Service
3.7 Date of Enter into Prostate Cancer Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Treatment Drugs Breakdown Data by Type
4.1 Global Prostate Cancer Treatment Drugs Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Treatment Drugs Forecasted Market Size by Type (2024-2033)
5 Prostate Cancer Treatment Drugs Breakdown Data by Application
5.1 Global Prostate Cancer Treatment Drugs Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Treatment Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Prostate Cancer Treatment Drugs Market Size (2018-2033)
6.2 North America Prostate Cancer Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Prostate Cancer Treatment Drugs Market Size by Country (2018-2023)
6.4 North America Prostate Cancer Treatment Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Cancer Treatment Drugs Market Size (2018-2033)
7.2 Europe Prostate Cancer Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Prostate Cancer Treatment Drugs Market Size by Country (2018-2023)
7.4 Europe Prostate Cancer Treatment Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Treatment Drugs Market Size (2018-2033)
8.2 Asia-Pacific Prostate Cancer Treatment Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Cancer Treatment Drugs Market Size (2018-2033)
9.2 Latin America Prostate Cancer Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Prostate Cancer Treatment Drugs Market Size by Country (2018-2023)
9.4 Latin America Prostate Cancer Treatment Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Treatment Drugs Market Size (2018-2033)
10.2 Middle East & Africa Prostate Cancer Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Prostate Cancer Treatment Drugs Introduction
11.1.4 Johnson & Johnson Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.1.5 Johnson & Johnson Recent Development
11.2 Astella
11.2.1 Astella Company Detail
11.2.2 Astella Business Overview
11.2.3 Astella Prostate Cancer Treatment Drugs Introduction
11.2.4 Astella Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.2.5 Astella Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Prostate Cancer Treatment Drugs Introduction
11.3.4 Sanofi Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.3.5 Sanofi Recent Development
11.4 Ipsen
11.4.1 Ipsen Company Detail
11.4.2 Ipsen Business Overview
11.4.3 Ipsen Prostate Cancer Treatment Drugs Introduction
11.4.4 Ipsen Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.4.5 Ipsen Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Prostate Cancer Treatment Drugs Introduction
11.5.4 Bayer Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.5.5 Bayer Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Prostate Cancer Treatment Drugs Introduction
11.6.4 AstraZeneca Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Dendreon
11.7.1 Dendreon Company Detail
11.7.2 Dendreon Business Overview
11.7.3 Dendreon Prostate Cancer Treatment Drugs Introduction
11.7.4 Dendreon Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.7.5 Dendreon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Zytiga
Table 3. Key Players of Gonax
Table 4. Key Players of Lupron
Table 5. Key Players of Zoladex
Table 6. Key Players of Decapeptyl
Table 7. Key Players of Eligard
Table 8. Key Players of Vantas
Table 9. Key Players of Casodex
Table 10. Key Players of Others
Table 11. Global Prostate Cancer Treatment Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 12. Global Prostate Cancer Treatment Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 13. Global Prostate Cancer Treatment Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 14. Global Prostate Cancer Treatment Drugs Market Share by Region (2018-2023)
Table 15. Global Prostate Cancer Treatment Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 16. Global Prostate Cancer Treatment Drugs Market Share by Region (2024-2033)
Table 17. Prostate Cancer Treatment Drugs Market Trends
Table 18. Prostate Cancer Treatment Drugs Market Drivers
Table 19. Prostate Cancer Treatment Drugs Market Challenges
Table 20. Prostate Cancer Treatment Drugs Market Restraints
Table 21. Global Prostate Cancer Treatment Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 22. Global Prostate Cancer Treatment Drugs Market Share by Players (2018-2023)
Table 23. Global Top Prostate Cancer Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Treatment Drugs as of 2022)
Table 24. Ranking of Global Top Prostate Cancer Treatment Drugs Companies by Revenue (US$ Million) in 2022
Table 25. Global 5 Largest Players Market Share by Prostate Cancer Treatment Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Prostate Cancer Treatment Drugs Product Solution and Service
Table 28. Date of Enter into Prostate Cancer Treatment Drugs Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Prostate Cancer Treatment Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 31. Global Prostate Cancer Treatment Drugs Revenue Market Share by Type (2018-2023)
Table 32. Global Prostate Cancer Treatment Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 33. Global Prostate Cancer Treatment Drugs Revenue Market Share by Type (2024-2033)
Table 34. Global Prostate Cancer Treatment Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 35. Global Prostate Cancer Treatment Drugs Revenue Market Share by Application (2018-2023)
Table 36. Global Prostate Cancer Treatment Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 37. Global Prostate Cancer Treatment Drugs Revenue Market Share by Application (2024-2033)
Table 38. North America Prostate Cancer Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Prostate Cancer Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Prostate Cancer Treatment Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Prostate Cancer Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Europe Prostate Cancer Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Europe Prostate Cancer Treatment Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 44. Asia-Pacific Prostate Cancer Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 45. Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 46. Asia-Pacific Prostate Cancer Treatment Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 47. Latin America Prostate Cancer Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Latin America Prostate Cancer Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 49. Latin America Prostate Cancer Treatment Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 50. Middle East & Africa Prostate Cancer Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 51. Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 52. Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 53. Johnson & Johnson Company Detail
Table 54. Johnson & Johnson Business Overview
Table 55. Johnson & Johnson Prostate Cancer Treatment Drugs Product
Table 56. Johnson & Johnson Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 57. Johnson & Johnson Recent Development
Table 58. Astella Company Detail
Table 59. Astella Business Overview
Table 60. Astella Prostate Cancer Treatment Drugs Product
Table 61. Astella Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 62. Astella Recent Development
Table 63. Sanofi Company Detail
Table 64. Sanofi Business Overview
Table 65. Sanofi Prostate Cancer Treatment Drugs Product
Table 66. Sanofi Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 67. Sanofi Recent Development
Table 68. Ipsen Company Detail
Table 69. Ipsen Business Overview
Table 70. Ipsen Prostate Cancer Treatment Drugs Product
Table 71. Ipsen Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 72. Ipsen Recent Development
Table 73. Bayer Company Detail
Table 74. Bayer Business Overview
Table 75. Bayer Prostate Cancer Treatment Drugs Product
Table 76. Bayer Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 77. Bayer Recent Development
Table 78. AstraZeneca Company Detail
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Prostate Cancer Treatment Drugs Product
Table 81. AstraZeneca Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Dendreon Company Detail
Table 84. Dendreon Business Overview
Table 85. Dendreon Prostate Cancer Treatment Drugs Product
Table 86. Dendreon Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 87. Dendreon Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Treatment Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Prostate Cancer Treatment Drugs Market Share by Type: 2022 VS 2033
Figure 3. Zytiga Features
Figure 4. Gonax Features
Figure 5. Lupron Features
Figure 6. Zoladex Features
Figure 7. Decapeptyl Features
Figure 8. Eligard Features
Figure 9. Vantas Features
Figure 10. Casodex Features
Figure 11. Others Features
Figure 12. Global Prostate Cancer Treatment Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 13. Global Prostate Cancer Treatment Drugs Market Share by Application: 2022 VS 2033
Figure 14. Hospitals Case Studies
Figure 15. Ambulatory Surgical Centers Case Studies
Figure 16. Clinics Case Studies
Figure 17. Prostate Cancer Treatment Drugs Report Years Considered
Figure 18. Global Prostate Cancer Treatment Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 19. Global Prostate Cancer Treatment Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 20. Global Prostate Cancer Treatment Drugs Market Share by Region: 2022 VS 2033
Figure 21. Global Prostate Cancer Treatment Drugs Market Share by Players in 2022
Figure 22. Global Top Prostate Cancer Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Treatment Drugs as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Prostate Cancer Treatment Drugs Revenue in 2022
Figure 24. North America Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. North America Prostate Cancer Treatment Drugs Market Share by Country (2018-2033)
Figure 26. United States Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Europe Prostate Cancer Treatment Drugs Market Share by Country (2018-2033)
Figure 30. Germany Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Asia-Pacific Prostate Cancer Treatment Drugs Market Share by Region (2018-2033)
Figure 38. China Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Japan Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. South Korea Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Southeast Asia Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. India Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Australia Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Latin America Prostate Cancer Treatment Drugs Market Share by Country (2018-2033)
Figure 46. Mexico Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Brazil Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa Prostate Cancer Treatment Drugs Market Share by Country (2018-2033)
Figure 50. Turkey Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Saudi Arabia Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 53. Astella Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 54. Sanofi Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 55. Ipsen Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 56. Bayer Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 57. AstraZeneca Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 58. Dendreon Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries